Literature DB >> 24907358

Genetic characterization of acquired aplastic anemia by targeted sequencing.

Michael Heuser1, Carola Schlarmann2, Vera Dobbernack2, Victoria Panagiota2, Lutz Wiehlmann3, Carolin Walter4, Fabian Beier5, Patrick Ziegler5, Haiyang Yun2, Sofia Kade2, Aylin Kirchner2, Liu Huang6, Christian Koenecke2, Matthias Eder2, Tim H Brümmendorf5, Martin Dugas4, Arnold Ganser2, Felicitas Thol2.   

Abstract

Entities:  

Keywords:  MDS-related mutations; aplastic anemia

Mesh：

Substances：

Year:  2014        PMID： 24907358      PMCID： PMC4562551          DOI： 10.3324/haematol.2013.101642

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  16 in total

Review 1.  How I treat acquired aplastic anemia.

Authors:  Phillip Scheinberg; Neal S Young
Journal:  Blood       Date:  2012-04-19       Impact factor: 22.113

2.  Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes.

Authors:  Felicitas Thol; Inna Friesen; Frederik Damm; Haiyang Yun; Eva M Weissinger; Jürgen Krauter; Katharina Wagner; Anuhar Chaturvedi; Amit Sharma; Martin Wichmann; Gudrun Göhring; Christiane Schumann; Gesine Bug; Oliver Ottmann; Wolf-Karsten Hofmann; Brigitte Schlegelberger; Michael Heuser; Arnold Ganser
Journal:  J Clin Oncol       Date:  2011-05-16       Impact factor: 44.544

3.  A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  André Tichelli; Hubert Schrezenmeier; Gérard Socié; Judith Marsh; Andrea Bacigalupo; Ulrich Dührsen; Anke Franzke; Michael Hallek; Eckhard Thiel; Martin Wilhelm; Britta Höchsmann; Alain Barrois; Kim Champion; Jakob R Passweg
Journal:  Blood       Date:  2011-01-13       Impact factor: 22.113

4.  Exome sequencing identifies MPL as a causative gene in familial aplastic anemia.

Authors:  Amanda J Walne; Arran Dokal; Vincent Plagnol; Richard Beswick; Michael Kirwan; Josu de la Fuente; Tom Vulliamy; Inderjeet Dokal
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

5.  SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.

Authors:  Manuel G Afable; Marcin Wlodarski; Hideki Makishima; Mohammed Shaik; Mikkael A Sekeres; Ramon V Tiu; Matt Kalaycio; Christine L O'Keefe; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

6.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

7.  Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia.

Authors:  A A Lane; O Odejide; N Kopp; S Kim; A Yoda; R Erlich; N Wagle; G A Abel; S J Rodig; J H Antin; D M Weinstock
Journal:  Leukemia       Date:  2013-02-01       Impact factor: 11.528

8.  Acquired mutations in TET2 are common in myelodysplastic syndromes.

Authors:  Saskia M C Langemeijer; Roland P Kuiper; Marieke Berends; Ruth Knops; Mariam G Aslanyan; Marion Massop; Ellen Stevens-Linders; Patricia van Hoogen; Ad Geurts van Kessel; Reinier A P Raymakers; Eveline J Kamping; Gregor E Verhoef; Estelle Verburgh; Anne Hagemeijer; Peter Vandenberghe; Theo de Witte; Bert A van der Reijden; Joop H Jansen
Journal:  Nat Genet       Date:  2009-05-31       Impact factor: 38.330

9.  Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia.

Authors:  Thomas L Dunwell; Rachel E Dickinson; Tatjana Stankovic; Ashraf Dallol; Victoria Weston; Belinda Austen; Daniel Catchpoole; Eamonn R Maher; Farida Latif
Journal:  Epigenetics       Date:  2009-05-01       Impact factor: 4.528

10.  MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia.

Authors:  M Clarke; S Dumon; C Ward; R Jäger; S Freeman; B Dawood; L Sheriff; M Lorvellec; R Kralovics; J Frampton; P García
Journal:  Leukemia       Date:  2012-08-22       Impact factor: 11.528
View more
  22 in total

1.  Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.

Authors:  Daria V Babushok; Monica Bessler; Timothy S Olson
Journal:  Leuk Lymphoma       Date:  2015-12-23

Review 2.  Clonal hematopoiesis.

Authors:  Max Jan; Benjamin L Ebert; Siddhartha Jaiswal
Journal:  Semin Hematol       Date:  2016-10-20       Impact factor: 3.851

Review 3.  A brief, but comprehensive, guide to clonal evolution in aplastic anemia.

Authors:  Daria V Babushok
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 4.  Diagnosis and Treatment of Aplastic Anemia.

Authors:  Scott A Peslak; Timothy Olson; Daria V Babushok
Journal:  Curr Treat Options Oncol       Date:  2017-11-16

5.  Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies.

Authors:  Nils Winkelmann; Vivien Schäfer; Jenny Rinke; Alexander Kaiser; Philipp Ernst; Sebastian Scholl; Andreas Hochhaus; Thomas Ernst
Journal:  J Cancer Res Clin Oncol       Date:  2017-09-14       Impact factor: 4.553

6.  Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia.

Authors:  Bogdan Dumitriu; Xingmin Feng; Danielle M Townsley; Yasutaka Ueda; Tetsuichi Yoshizato; Rodrigo T Calado; Yanqin Yang; Yoshiyuki Wakabayashi; Sachiko Kajigaya; Seishi Ogawa; Jun Zhu; Neal S Young
Journal:  Blood       Date:  2014-11-18       Impact factor: 22.113

7.  Origins of myelodysplastic syndromes after aplastic anemia.

Authors:  Eiju Negoro; Yasunobu Nagata; Michael J Clemente; Naoko Hosono; Wenyi Shen; Aziz Nazha; Tetsuichi Yoshizato; Cassandra Hirsch; Bartlomiej Przychodzen; Reda Z Mahfouz; Teodora Kuzmanovic; Mikkael A Sekeres; Hideki Makishima; Seishi Ogawa; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2017-09-11       Impact factor: 22.113

8.  Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?

Authors:  Felicitas Thol; Uwe Platzbecker
Journal:  Blood Adv       Date:  2019-11-12

9.  Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia.

Authors:  Tatsuya Imi; Takamasa Katagiri; Kazuyoshi Hosomichi; Yoshitaka Zaimoku; Viet Hoang Nguyen; Noriharu Nakagawa; Atsushi Tajima; Tetsuichi Yoshizato; Seishi Ogawa; Shinji Nakao
Journal:  Blood Adv       Date:  2018-05-08

Review 10.  Clonal hematopoiesis in acquired aplastic anemia.

Authors:  Seishi Ogawa
Journal:  Blood       Date:  2016-04-27       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.